Accueil   Diary - News   All news MaaT Pharma Unveils the First GMP-Compliant European Fecal Microbiota Transfer Platform

MaaT Pharma Unveils the First GMP-Compliant European Fecal Microbiota Transfer Platform

Logo MaâT 4e versionMajor treatments such as high-dose antibiotic therapies and chemotherapies can lead to serious complications and create a gut microbiota imbalance (formerly called intestinal flora).

Thanks to the €16M funding round led by multiple venture capitalists, in the last 18 months, MaaT Pharma aims to correct this imbalance.

This biotech company, a specialist in intestinal microbiota, has launched its clinical trials and officially opened its platform for the production of clinical batches on November 3rd, 2016.

Read the press release